ID: MRFR/F-B & N/6943-HCR | 111 Pages | Published By Snehal Singh on March 2023
Digestive Enzyme Supplements Market is expected to cross USD 1.02 Billion by 2027 at a CAGR of 6.40% during the forecast period of 2020 to 2027.
$1.02 Billion
6.40%
Europe
2020 - 2027
Market Synopsis
Digestive Enzyme Supplements Market is expected to cross USD 1.02 Billion by 2027 at a CAGR of 6.40% during the forecast period of 2020 to 2027. It is a perfect competition market due to the presence of numerous active buyers and sellers. The market is governed by several regional and local players recognized through their prominent brands. For instance, Danone Nutricia is a subsidiary of Danone India and provides digestive enzyme supplements in Asia-Pacific under the brand name Aptamil. Market players are focusing on product development by investing in R&D and establishing strategic partnerships with retailers and distributors to strengthen and expand their distribution networks.
Market Synopsis
The Global Digestive Enzyme Supplements Market is growing. These enzymes help manage digestive tract conditions such as exocrine or endocrine pancreatic insufficiency, constipation, irritable bowel syndrome, inflammation of the bowels, indigestion, and bloating. Digestive enzyme supplements also aid in treating other ailments such as pancreatic cancer, diabetes, and cystic fibrosis. With several proven medicinal properties, the use of digestive enzyme supplements is increasing in preventive healthcare to ensure health and vitality. The increased prevalence of ailments and conditions of the digestive tract due to changes in lifestyle has led to a rise in awareness, which is a major driver for market growth.
However, the stringent regulations laid out by the US Food and Drug Administration under the Dietary Supplement Health and Education Act of 1994 and the Natural Health Products Regulations in Canada are expected to hamper the growth of the global digestive enzyme supplements market. A hike in demand for probiotic and prebiotic supplements among the global populace is also expected to hinder market growth. According to MRFR analysis, the global prebiotics market is expected to register a CAGR of 6.40% during the forecast period of 2020 to 2027.
Market USP
Prevention of digestive health conditions with few side effects.
Market Drivers
Segmentation
By Source
By Product Type
By Distribution Channel
By Region
Key Players
Report Attribute/Metric | Details |
---|---|
Market Size | USD 1.02 Billion |
CAGR | 6.40% (2020-2027) |
Base Year | 2019 |
Forecast Period | 2020-2027 |
Historical Data | 2018 |
Forecast Units | Value (USD Billion) |
Report Coverage | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends |
Segments Covered | By Source, By Product Type, By Distribution Channel, and By Region |
Geographies Covered | North America, Europe, Asia-Pacific, and Rest of the World (RoW) |
Key Vendors | Enzymes Inc. (US), Klaire Laboratories (US), Amano Enzyme Inc. (Japan), Enzymedica (US), Advanced Enzyme Technologies (India), National Enzyme Company (US), Metagenics Inc. (US), Danone India (Nutricia) (India), Vox Nutrition (US), Douglas Laboratories (US) |
Key Market Opportunities | Changes in lifestyle has led to a rise in awareness |
Key Market Drivers | Increased public awareness regarding healthy lifestyles |
Digestive enzyme supplements market would reach a valuation of USD 1.02 billion.
Digestive enzyme supplements market CAGR would be 6.40% during the forecast period.
Animal segment would take the charge of digestive enzyme supplements market.
Tablets and capsules would head digestive enzyme supplements market.
Non-store-based segment would lead digestive enzyme supplements market.